Role of Dynamic Susceptibility Contrast Perfusion MRI in Glioma Progression Evaluation

Figure 1

Example of region of interest (ROI) for measurement of CBV (the circle in red). This 37-year-old female patient with pathologically proven glioblastoma was ascribed to true progression group.